China
Builds general-purpose humanoids and rehabilitation robots.
Est. valuation
$200M+ funding and $800M+ valuation reported
Products to market
ShippingIndependentsource ↗GR-1 reportedly delivered in small quantities to universities and AI companies; no unit count imported.
Product dossier
Flagship productGR-1, GR-2
The “brain”In-house humanoid control and rehabilitation robotics stack
Real-world tractionCommercial humanoid platform with healthcare and rehabilitation robotics roots.
ProvenanceCompany-statedIndependentEstimate